|
Malignant neoplasm of breast
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
Our data provided the first evidence that C10orf10 expression was frequently decreased in breast cancer tissues, and low expression of C10orf10 may be an important prognostic factor for poorer survival time of breast cancer patients.
|
24936657 |
2014 |
|
Breast Carcinoma
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
Our data provided the first evidence that C10orf10 expression was frequently decreased in breast cancer tissues, and low expression of C10orf10 may be an important prognostic factor for poorer survival time of breast cancer patients.
|
24936657 |
2014 |
|
Malignant neoplasm of breast
|
0.310 |
Biomarker
|
disease |
CTD_human |
ERE-independent ERalpha target genes differentially expressed in human breast tumors.
|
16298037 |
2005 |
|
Breast Carcinoma
|
0.310 |
Biomarker
|
disease |
CTD_human |
ERE-independent ERalpha target genes differentially expressed in human breast tumors.
|
16298037 |
2005 |
|
Endometriosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis.
|
20864642 |
2011 |
|
Endometrioma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis.
|
20864642 |
2011 |
|
Lipoidosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells.
|
17175557 |
2007 |
|
Lipoidosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Improved toxicogenomic screening for drug-induced phospholipidosis using a multiplexed quantitative gene expression ArrayPlate assay.
|
16919414 |
2006 |
|
Lipoidosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.
|
15342952 |
2005 |
|
Mammary Neoplasms, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
ERE-independent ERalpha target genes differentially expressed in human breast tumors.
|
16298037 |
2005 |
|
Mammary Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
ERE-independent ERalpha target genes differentially expressed in human breast tumors.
|
16298037 |
2005 |
|
Mammary Carcinoma, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
ERE-independent ERalpha target genes differentially expressed in human breast tumors.
|
16298037 |
2005 |
|
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Importantly, in a xenograft mouse model of human colon cancer, we further confirmed that baicalin treatment dramatically inhibited tumor growth, which was due to the induction of tumor cellular senescence via the upregulation of DEPP and the activation of Ras/Raf/MEK/ERK signaling in vivo.
|
29440765 |
2018 |
|
Neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Targeting FOXO3/DEPP-triggered autophagy is a promising strategy to sensitize neuroblastoma cells to chemotherapy.
|
28545464 |
2017 |
|
Central neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Targeting FOXO3/DEPP-triggered autophagy is a promising strategy to sensitize neuroblastoma cells to chemotherapy.
|
28545464 |
2017 |
|
Childhood Neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Targeting FOXO3/DEPP-triggered autophagy is a promising strategy to sensitize neuroblastoma cells to chemotherapy.
|
28545464 |
2017 |
|
Neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
We report for the first time that DEPP regulates ROS detoxification and localizes to peroxisomes and mitochondria in neuroblastoma cells.
|
25261981 |
2014 |
|
Central neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
We report for the first time that DEPP regulates ROS detoxification and localizes to peroxisomes and mitochondria in neuroblastoma cells.
|
25261981 |
2014 |
|
Childhood Neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
We report for the first time that DEPP regulates ROS detoxification and localizes to peroxisomes and mitochondria in neuroblastoma cells.
|
25261981 |
2014 |
|
Neoplasms
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Possible functions of the highly expressed gene Depp include tumor vascularization.
|
17486380 |
2007 |
|
Colorectal Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Recently, small studies of colorectal carcinomas (CRCs) have suggested an incidence of EML4-ALK translocations of 0.4% to 2.4% and FIG-ROS1 translocations of 0.8%.
|
24992173 |
2015 |
|
Gallbladder Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We found that six out of 65 (9%) BTC patients were positive for the FIG-ROS1 fusion, comprising two out of 14 (14%) gallbladder carcinoma (GBC) patients and four out of 25 (16%) extrahepatic cholangiocarcinoma (ECC) patients.
|
25231053 |
2014 |
|
Bile duct carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We developed a new, quick, specific, and sensitive PCR test to screen for the FIG-ROS1 fusion and applied it to a series of Italian patients with bile duct carcinoma (BTC).
|
25231053 |
2014 |
|
Extrahepatic Cholangiocarcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In conclusion, 14-16% of GBC and ECC were positive for FIG-ROS1.
|
25231053 |
2014 |
|
Hypoglycemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Indeed, the α-cell-specific insulin receptor knockout (αIRKO) mouse manifests hypersecretion of glucagon in the postprandial stage and exhibits defective secretion in fasting-induced hypoglycaemia, together mimicking the α-cell defects observed in type 2 diabetes.
|
21824253 |
2011 |